Trial intelligence / Profile preview

Basel ProDex: Dexmedetomidine vs Propofol for ICU Delirium

NCT02807467Phase 4Terminated

Sponsor
University Hospital Basel
Start
Mar 2019
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in delirium, sponsored by University Hospital Basel. Started Mar 2019; status: terminated.

02

Drugs

dexmedetomidine
03

Conditions

delirium

Beyond the preview

Go deeper on NCT02807467.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02807467.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call